Protagonist Therapeutics, Inc. (PTGX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 5.55B |
| Enterprise Value | 5.43B |
| P/E Ratio | -63.84 |
| PEG Ratio | 0.18 |
| Price/Sales Ratio | 99.88 |
| Price/Book Ratio | 11.42 |
| Enterprise/Revenue | 97.4 |
| Enterprise/EBITDA | -63.32 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.55 |
| Operating Margin | -1.92 |
| Return On Assets | -0.16 |
| Return On Equity | -0.18 |
| Revenue | 46.02M |
| Revenue/Share | 1.14 |
| Gross Profit | 44.79M |
| EBITDA | -128.09M |
| Net Income | -130.15M |
| Diluted EPS | -2.05 |
| Total Cash | 547.79M |
| Total Cash/Share | 8.42 |
| Total Debt | 9.78M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 17.76 |
| Book Value Per Share | 10.07 |
| 52-Week Change | 115.57 |
| 52-Week High | 116.57 |
| 52-Week Low | 49.38 |
| Moving Average 50 Days | 102.3 |
| Moving Average 200 Days | 87.5 |
| Average Volume | 665,861 |
| Shares Outstanding | 64.31M |
| % Held by Institutions | 123.87 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |